@Patent_SUN Profile picture

Patent SUN

@Patent_SUN

🐭🇯🇵Japanese patent attorney specializing in patent. Stand up against the mRNA problems. We must not be bystanders to history that repeats itself.

Similar User
みかん photo

@kusattamikan123

kgp photo

@kgp008

のんれむ photo

@N_rem_sleep

CHINSODO photo

@chinsodo

アッコロ photo

@vdow9J35r2iFkZx

tarezou_p2@「明治」で日本は終わったのだよw photo

@tarezou_p2

25 photo

@ofkohg

めめ*meme photo

@575meme575

山奥 photo

@9lJRPm6eRpJiCeX

おちゃから photo

@XfSHBsdguUpQ35R

まぶな photo

@Kuriperry

青りんご photo

@5aoringo5

ダイダロス photo

@pn6YZ1V27m5yCJO

フラン photo

@huran_seven

cerise photo

@cherry16265864

Pinned

Planned Revision: Some interpretations of the TGA and EMA documents were clarified through the BioNTech patent, and some values are to be revised.

Theme: Calling and challenging for quantitatively eliminating the underestimation of the DNA contamination in the qPCR ◆The estimated amount of the DNA contamination when the underestimation is eliminated significantly exceeds the regulation amount. Regarding the Pfizer…

Tweet Image 1


Patent SUN Reposted

PMDAの審議結果報告書(2023/11/28)によれば、実験に使った自己増殖型レプリコンには、スパイク蛋白の遺伝子は入っていない別物のようです。とすると細胞間伝播の性能が著しく落ちるため、増殖能力も落ち長く続かないでしょう。 違うもので実験して承認、こんなのばっか。 pmda.go.jp/drugs/2023/P20…

Tweet Image 1

私も知りたい。 ・「(スパイクタンパクは)私どもの実験では31日後にほぼ消滅することが確認されています by Meiji」(マネーポストwebの記事より) ・mRNA も15〜30日後にはほとんど検出されなくなる(画像) のなら、なぜ半年以上も高い抗体価が続くのか。 news.yahoo.co.jp/articles/722d3…

Tweet Image 1


Patent SUN Reposted

When did the regulations go to 1:1000 DNA:RNA? That’s a lie right in the abstract. They are also playing games using phenol/chloroform precipitation which loses all the DNA under 200bp. Only 4 vials. No mention of how fluorometry under estimates the DNA 70% as it shortens

Tweet Image 1

Patent SUN Reposted

It's a preprint from a University where the authors all publish with authors who have heavy pharma interests. SSRN originally published #surgisphere Multiple red flags. It's a set up. @Kevin_McKernan app.frame.io/presentations/… archive.md/wEZFJ papers.ssrn.com/sol3/papers.cf…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

This is a refutation thesis on residual DNA issue. It is necessary to verify in detail.

the mRNA-LNP dna contamination gaslighting goes into the next round @kevin_mckernan papers.ssrn.com/sol3/papers.cf…

Tweet Image 1


Good news and nice information

I am confounded. This is beyond reckless. @Kevin_McKernan @jikkyleaks @NassMeryl @RWMaloneMD @drdrew We will talk soon about this. businesswire.com/news/home/2024…



Patent SUN Reposted

Powerful testimony by dr. Kevin McKernan: "Thank you, Senator Johnson. I very much appreciate you giving us this audience. Many in this audience have been subjected to years of censorship on this topic. What I want to talk to you today is about the DNA contamination that our team…


Patent SUN Reposted

childrenshealthdefense.org/defender/hib-v… Le vaccin retiré "tranquillement" du marché en 2007 est maintenant lié à 19 maladies - 35 millions de bébés qui ont reçu le vaccin sont maintenant à risque à l'âge adulte Le vaccin pédiatrique HibTITER sans thimérosal commercialisé par Wyeth (depuis…


Patent SUN Reposted

Université de Wuhan et de Washington : les étudiants thésards de Yan Huan et Shi Zhengli pensent jouer au légo en créant de nouveaux récepteurs mix de pathogènes tous redoutables. Pour créer dans la foulée de nouveaux vaccins... Vous avez dit l'égo ? #WIV #Frankenviruses

👨‍🔬👩‍🔬Prof. Yan Huan of #WHU and his team, in collaboration with Prof. Shi Zhengli of Guangzhou Laboratory and Prof. David Veesler of @UW have revealed a groundbreaking strategy to engineer functional customized viral receptors (CVRs) in @Nature 🔬This innovative "LEGO-like"…

Tweet Image 1
Tweet Image 2
Tweet Image 3


Patent SUN Reposted

Pfizer Batch Code Starting with "E" Means "Everyone is Potentially at Risk" Jabbed? Keep Your Vaccine Records and Search Your Batch Pfizer’s lots or batches have been evaluated and studied for variation in risk by Schmeling, Manniche, and Jablonowski. All three studies have…

Tweet Image 1

アストラゼネカのRSVワクチン「ニルセビマブ」に関する懸念を表明した論文にも目を通してください。 Beyfortus®(Nirsevimab)予防接種キャンペーンの分析:RSV予防における有効性、バイアス、およびADEリスク preprints.org/manuscript/202…

pubmed.ncbi.nlm.nih.gov/39329969/ Banoun H. Analysis of Beyfortus® (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention. Curr Issues Mol Biol. 2024 Sep 18;46(9):10369-10395. doi: 10.3390/cimb46090617. PMID: 39329969 mdpi.com/1467-3045/46/9…



Patent SUN Reposted

Pourquoi la FDA et Pfizer, reconnaissant le risque d’hypertension gestationnelle, ont-ils autorisé l’administration d’Abrysvo aux femmes enceintes présentant des symptômes de ce syndrome ?

This post is unavailable.

Thank you for the info. That is a good example of how important it is to share technical information for me. Multiple small pieces of information come together to form a collective intelligence. Patent is considered to be granted to new and superior invention, but this is merely…


Loading...

Something went wrong.


Something went wrong.